Pradžia EN

Sveikatos srities partnerystės pasiūlymai

Tematika

Institucija

Šalis

Papildoma informacija

HORIZON-HLTH-2022-STAYHLTH-02-01

HORIZON-HLTH-2022- DISEASE-07-02
HORIZON-HLTH-2022-TOOL-11-01 -
AO Research Institute Davos
Dr Tiziano Serra tiziano.serra@aofoundation.org

CH

AO Research Institute Davos (ARI) is recognized as a research-leader in Switzerland, Europe, and the world. ARI's purpose is advancing patient care through innovative orthopaedic research and development. Its goals are to contribute high-quality applied preclinical research and development focused on clinical applications and solutions, to investigate and improve the

performance of surgical procedures, devices, and substances, and to build a close relationship with the AO

medical community, academic societies, and universities. Regenerative Orthopaedics Program has

established research activities in the field of bone, cartilage, and intervertebral disc, with a major focus on regenerative medicine, biofabrication, cell and gene therapy. The Sound Guided Tissues Regeneration Group (SGTR) activities focus on the translation of innovative biofabrication technologies for tissue

regeneration and development of cutting-edge 3-D in vitro disease models for drug screening and personalized medicine.

Be aware that contribution/participation from Switzerland is eligible and that participation is funded by national funding.

TOPIC ID: HORIZON-HLTH-2022-STAYHLTH-02-01

HORIZON-HLTH-2022-DISEASE-03-01 HORIZON-HLTH-2022-DISEASE-07-03 HORIZON-HLTH-2022-TOOL-11-01 HORIZON-MISS-2021-CANCER-02-01

University of Sfax-Tunisia
Riadh Ben Mansour

riadh.benmansour@fss.usf.tn
TN

Genetic, epigenetic and functional studies of human pathologies.

Implication of oxidative stress in human pathologies: assessing of patient's oxidative

profile (lipid peroxidation, antioxidant enzymes' activities, DNA damage, etc.)

 Cell culture: Primary cell culture, cell line culture, PBMC and Neutrophils extraction,

  Bioinformatics: DNA, RNA and Proteins Blast, structure function relationship studies,

Protein modeling, Docking, Molecular dynamics simulation,

 Flow cytometry: Multiparameter Phenotyping of Human PBMCs, Proliferation

analysis, Cell cycle analysis, Apoptosis analysis,

Keywords: Mitochondrial pathologies, endocrine diseases, autoimmune diseases, proteomics studies,

genetic studies, neutrophil, PBMC, cell transfection, cell culture, oxidative stress.

Any

 

Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP)

cspadafora@indicasat.org.pa; carmenzaspadafora@gmail.com

 

 

PA

Lorena Coronado, Ph.D. Electromagnetism and microorganisms.

Ricardo Correa, Ph.D. Extracellular vesicles, adenovirus.

Laura Pineda, B.Sc., screening of activity against P. falciparum and L. donovani.

Michelle Ng, B.Sc., screening of activity against T. cruzi, T. gondii and cytotoxicity assays.

Doriana Dorta, B.Sc., biophysical studies of P. falciparum.

Jafeth Carrasco, B.Sc., molecular biology, synthetic biology.

HORIZON-HLTH-2022-DISEASE-03-01

www.bentenbiotech.com

Jorge Wenzel

jorgewenzel@bentenbiotech.com

UY

Benten Biotech (www.bentenbiotech.com) is an SME that develops innovative products and processes in biotechnology, focused on animal and human health. Within our areas of expertise are the discovery, R&D and production for preclinical phases of monodomain recombinant monoclonal antibodies (VHH antibodies, recombinant monodomain antibodies). Within the capabilities of our platform is native or recombinant antigens development, and its standardization for immunoassays or immunotherapies based on monodomain antibodies. At Benten we are continually looking for partners that allow us to enhance joint value propositions, co-develop new products or processes to quickly advance in the development of health solutions. We are particularly interested in participating in innovation clusters with companies from the EU or associated countries, to contribute in phases of discovery, R&D as well as with preclinical candidates in immunodiagnostics and immunotherapies using VHH antibodies. We need partners to perform clinical phases or IVD validation for the products based in VHH antibodies candidates that Benten develops. info@bentenbiotech.com

HORIZON-HLTH-2022-DISEASE-07-03

The Academic College of Tel-Aviv Yaffo in Israel Dr. Cendrine Bursztein Lipsicas

IL

The current study will provide knowledge on the rate of mental disorders, STB and use of services among LGBTQ youth and will help to define intervenable risk factors in this population. The findings will serve health related decision-makers to define the resources needed for the promotion of adapted mental health services